Cargando…

Experimental Models to Define the Genetic Predisposition to Liver Cancer

Hepatocellular carcinoma (HCC) is a frequent human cancer and the most frequent liver tumor. The study of genetic mechanisms of the inherited predisposition to HCC, implicating gene–gene and gene–environment interaction, led to the discovery of multiple gene loci regulating the growth and multiplici...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pascale, Rosa M., Simile, Maria M., Peitta, Graziella, Seddaiu, Maria A., Feo, Francesco, Calvisi, Diego F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826893/ https://www.ncbi.nlm.nih.gov/pubmed/31569678 http://dx.doi.org/10.3390/cancers11101450

Ejemplares similares

Genetic Predisposition to Hepatocellular Carcinoma
por: Pascale, Rosa M., et al.
Publicado: (2022)

Alterations of Methionine Metabolism as Potential Targets for the Prevention and Therapy of Hepatocellular Carcinoma
por: Pascale, Rosa M., et al.
Publicado: (2019)

MicroRNA-203 impacts on the growth, aggressiveness and prognosis of hepatocellular carcinoma by targeting MAT2A and MAT2B genes
por: Simile, Maria M., et al.
Publicado: (2019)

Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury
por: Simile, Maria M., et al.
Publicado: (2018)

Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease
por: Simile, Maria M., et al.
Publicado: (2016)

S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
por: Pascale, Rosa M., et al.
Publicado: (2022)

The Warburg Effect 97 Years after Its Discovery
por: Pascale, Rosa Maria, et al.
Publicado: (2020)

Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase
por: Simile, Maria M., et al.
Publicado: (2021)

Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value
por: Evert, M, et al.
Publicado: (2013)

Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis
por: Cigliano, Antonio, et al.
Publicado: (2017)

Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis
por: Jia, Jiaoyuan, et al.
Publicado: (2020)

Genetic predisposition in nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Genetic Predisposition to Cancer
por: Eisinger, F
Publicado: (2006)

Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
por: Klemm, Sophie, et al.
Publicado: (2023)

Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice
por: Cigliano, Antonio, et al.
Publicado: (2017)

Genetic predisposition to lung cancer.
por: Law, M. R.
Publicado: (1990)

Genetic Predisposition to Clonal Hematopoiesis
por: Quiros, Pedro M., et al.
Publicado: (2023)

Genetic predisposition to cancer.
por: Ponder, B. A.
Publicado: (1991)

Genetic Predisposition to Neuroblastoma
por: Barr, Erin K., et al.
Publicado: (2018)

Cabozantinib for HCC Treatment, From Clinical Back to Experimental Models
por: Deng, Shanshan, et al.
Publicado: (2021)

Genetic predisposition models to COVID-19 infection
por: Darbeheshti, Farzaneh, et al.
Publicado: (2020)

Genetic Predisposition to Hematologic Malignancies in Childhood and Adolescence
por: Fabozzi, Francesco, et al.
Publicado: (2023)

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
por: Dongiovanni, Paola, et al.
Publicado: (2013)

Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials
por: Simile, Maria Maddalena, et al.
Publicado: (2019)

Genetic predispositions and childhood cancer.
por: Shannon, K
Publicado: (1998)

Principles of genetic predisposition to malignancies
por: Dębniak, Tadeusz, et al.
Publicado: (2008)

Genetic Predisposition to Infectious Disease
por: Klebanov, Nikolai
Publicado: (2018)

Genetic predisposition in pediatric oncology
por: Pruteanu, Doina Paula, et al.
Publicado: (2020)

Myelodysplastic syndrome with genetic predisposition
por: Park, Meerim
Publicado: (2021)

Liver proliferation: The GUCD1/NEDD4–1 connection
por: Calvisi, Diego F
Publicado: (2014)

Congruency of Genetic Predisposition to Lactase Persistence and Lactose Breath Test
por: Coluccia, Enza, et al.
Publicado: (2019)

Progressive Fibrosis Is Driven by Genetic Predisposition, Allo-immunity, and Inflammation in Pediatric Liver Transplant Recipients
por: Varma, S., et al.
Publicado: (2016)

ETV6 mutations define a new cancer predisposition syndrome
por: Kirkpatrick, Gregory, et al.
Publicado: (2015)

Debrisoquine metabolism and genetic predisposition to lung cancer.
por: Law, M. R., et al.
Publicado: (1989)

eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma
por: Steinmann, Sara M., et al.
Publicado: (2023)

Genetic predisposition to human lung cancer.
por: Heighway, J., et al.
Publicado: (1986)

Towards an understanding of genetic predisposition to migraine
por: Anttila, Verneri, et al.
Publicado: (2011)

Genetic Predisposition and Inflammatory Bowel Disease
por: El-Tawil,
Publicado: (2013)

Genetic Predisposition to Solid Pediatric Cancers
por: Capasso, Mario, et al.
Publicado: (2020)

Genetic clues for predisposition to severe disease
por: Flemming, Alexandra
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hfqp3ul10f6qmkmm2clcdtgfft